Research Article
Combined Application of Bevacizumab and Mitomycin C or Bevacizumab and 5-Fluorouracil in Experimental Glaucoma Filtration Surgery
Figure 1
Cell viability of ARPE-19 after treatment with bevacizumab (BVZ), mitomycin C (MMC), 5-fluorouracil (5-Fu), MMC + BVZ, and 5-Fu + BVZ. The cell viability of the control group was set at 100%. Unit: mg/mL. , .